Feature | February 22, 2013

ACR Dose Index Registry Surpasses Five Million Scans

Data will help establish national benchmarks for CT dose indices

February 22, 2013 — Since its launch, less than two years ago, more than 5 million computed tomography (CT) scans, and nearly 3 million exams, have been added to the American College of Radiology (ACR) Dose Index Registry (DIR) — bringing the ACR closer to establishing national benchmarks for CT dose indices, which will help ensure patients receive safe, quality imaging care.


The DIR is a radiology data registry that provides standardized, size-adjusted CT dose indices that facilitate meaningful comparisons — allowing imaging facilities to compare their CT dose indices to regional and national values. Information related to dose indices for all CT exams is collected, anonymized, transmitted to the ACR and stored in a database. Institutions are then provided with periodic feedback reports comparing their results by body part and exam type to aggregate results. A sample report containing actual aggregated data from a participating facility is available here: http://bit.ly/127WGpk.


Currently, the DIR has over 600 registered facilities, including private practices, hospital-based facilities and academic centers. Participation in the DIR is voluntary and will help radiologists meet the requirements for a Physician Quality Reporting System registry starting in 2014.


“As our early success demonstrates, patient safety and CT dose optimization is of utmost importance to radiology professionals, including radiologists, medical physicists and radiologic technologists. As we get closer to establishing national benchmarks for CT dose indices, I hope more imaging facilities will consider participating in the DIR. Having the ability to track dose reduction efforts over time and ultimately lower the radiation dose that Americans receive from medical imaging scans is invaluable,” said Richard Morin, Ph.D., chair of the ACR Dose Index Registry.  


The DIR is part of the overall ACR approach to medical radiation reduction, which includes mandatory accreditation of all medical imaging providers and greater adoption of computerized decision support/imaging ordering systems based on ACR appropriateness criteria.


For additional information about the ACR Dose Index Registry: http://bit.ly/VPNTXm


Related Content

Navidea, Mass General, Tc99m-tilmanocept, vulnerable plaque, cardiovascular disease, Harvard
News | Radiopharmaceuticals and Tracers| July 30, 2015
Navidea Biopharmaceuticals Inc. announced plans to move forward with a joint study of the ability of Tc99m-tilmanocept...
MSCs, stem cells, end-stageheart failure, retrograde, coronary sinus,
News | Stem Cell Therapies| July 29, 2015
A new clinical trial to test how a high dose of stem cells delivered via a method called retrograde coronary sinus...
Guerbet, acquisition, Mallinckrodt, CMDS business, contrast media, CT, MRI
News | Contrast Media| July 29, 2015
Guerbet announced that it has entered into a definitive agreement under which it will acquire Mallinckrodt's contrast...
heart failure, Adaptive CRT trial, AdaptivCRT algorithm, readmissions
News | Heart Failure| July 22, 2015
Heart failure patients had a significantly lower chance of being readmitted within 30 days of discharge when treated...
Direct Flow Medical, Transcatheter Aortic Valve System, SALUS Trial, FDA
News | Heart Valve Repair| July 22, 2015
Direct Flow Medical Inc. received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug...
Xarelto, anticoagulant protocol, discharge, outcomes, DVT, PE
News | Antiplatelet and Anticoagulation Therapies| July 21, 2015
Two companion papers published in Academic Emergency Medicine  address the question of when it is appropriate to...
UNC, biomarkers, severe heart disease, fructosamine, LDL cholesterol, Nichols
News | Cardiac Diagnostics| July 21, 2015
Insulin resistance affects tens of millions of Americans and is a big risk factor for heart disease. Yet, some people...
Feature | Atrial Fibrillation| July 20, 2015
A new study proves race and gender-related disparities exist in care for patients who have recently been diagnosed with...
Boston Scientific, fully absorbable scaffold, FAST study, resorbable
Feature | Stents Bioresorbable| July 20, 2015
Boston Scientific has initiated a study of the company's first fully resorbable drug-eluting scaffold system. The Fully...
Veryan Medical, BioMimics 3D femoropopliteal stent, MIMICS-2 study, PAD
News | Stents Peripheral| July 17, 2015
Veryan Medical announced that the first subject has been enrolled in their MIMICS-2 study at Universitäts-Herzzentrum...
Overlay Init